Blackwell Kimberly has filed 7 insider transactions across 3 companies since February 2024.
Most recent transaction: a grant/award of 44000 shares of Century Therapeutics, Inc. ($IPSC) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Century Therapeutics, Inc. | $IPSC | Blackwell Kimberly | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 13, 2025 | Monte Rosa Therapeutics, Inc. | $GLUE | Blackwell Kimberly | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 20, 2024 | Century Therapeutics, Inc. | $IPSC | Blackwell Kimberly | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 12, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Blackwell Kimberly | Not found | A | Stock Option (Right to Buy) | 22100 | $0.00 | 22,100.0000 | 51,396,961 | 9999.99% | 0.04% |
| Feb. 1, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Blackwell Kimberly | Chief Executive Officer | A | Common Stock | 250000 | $0.00 | 504,800.0000 | 0 | 98.12% | 0.00% |
| Feb. 1, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Blackwell Kimberly | Chief Executive Officer | F | Common Stock | 20655 | $11.69 | 484,145.0000 | 0 | 4.09% | 0.00% |
| Feb. 1, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Blackwell Kimberly | Chief Executive Officer | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |